Rising cost of weight-loss drugs has state Medicaid programs looking for solution

 Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid or state employee insurance programs are scrambling to lessen the budgetary squeeze from fast-rising costs

​Read More  ABC News: Business

​Business